#45 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Clinicians need to understand the growing population of older adults self-treating with cannabis for pain and sleep disorders, as this trend will persist regardless of ongoing policy debates, requiring evidence-based counseling about efficacy, drug interactions, and fall risks in this vulnerable population. The lack of definitive clinical guidance on cannabis use in aging creates a gap between patient demand and physician preparedness, making it essential for healthcare providers to stay informed on emerging research to safely advise patients considering or already using cannabis products.
# Clinical Summary The expansion of cannabis retail in Florida, exemplified by chains like Mint Cannabis, reflects growing consumer interest among older adults seeking cannabis for management of sleep disturbances, chronic pain, and general wellness. This trend underscores an important clinical reality: patients are increasingly self-selecting cannabis as a therapeutic option, particularly for conditions commonly encountered in geriatric populations, despite limited robust clinical evidence guiding optimal use in this vulnerable group. The ongoing debate surrounding cannabis regulation in Florida has implications for patient access, product standardization, and the clinical landscape, as physicians may encounter older patients already using or considering cannabis without clear guidance on efficacy, safety, or appropriate dosing. The lack of definitive research cited in this article highlights a critical gap between patient demand and evidence-based clinical practice, leaving clinicians without established protocols for counseling, monitoring, or integrating cannabis into comprehensive pain and sleep management strategies. Clinicians should anticipate increased patient inquiries about cannabis use, particularly from older adults, and should be prepared to discuss both potential benefits and risks while advocating for more rigorous clinical research to inform evidence-based prescribing practices.
“What we’re seeing in Florida and across the country is that older adults are finally willing to ask their physicians about cannabis for legitimate concerns like chronic pain and insomnia, and that conversation is exactly where the evidence should lead us, regardless of what the political debate does next.”
💊 The increasing use of cannabis among older adults for sleep, pain, and general wellness reflects both genuine patient interest and substantial knowledge gaps that clinicians must navigate carefully. While some observational data suggest potential benefits for specific conditions like chronic pain and insomnia, the evidence base remains limited by heterogeneous study designs, small sample sizes, and underrepresentation of older populations in clinical trials, making it difficult to establish clear risk-benefit profiles for this demographic. Healthcare providers should recognize that older adults are often taking multiple medications with significant drug interaction potential, have altered pharmacokinetics that may increase sensitivity to cannabinoids, and may conflate wellness marketing claims with clinical evidence. Rather than dismissing patient interest or uncritically endorsing products, clinicians can best serve older patients by conducting thorough medication and symptom reviews, discussing both the limited evidence and real risks (including falls, cognitive effects, and drug interactions), documenting cannabis use in the medical record,
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: